Tennessee Valley Asset Management Partners Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Tennessee Valley Asset Management Partners bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 323 shares of the financial services provider’s stock, valued at approximately $44,000.

Several other hedge funds also recently made changes to their positions in the company. Jacobi Capital Management LLC increased its position in iShares Biotechnology ETF by 3.7% during the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after purchasing an additional 91 shares during the period. PFG Investments LLC boosted its holdings in shares of iShares Biotechnology ETF by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock valued at $246,000 after buying an additional 93 shares in the last quarter. Huntington National Bank boosted its holdings in shares of iShares Biotechnology ETF by 7.4% during the 3rd quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock valued at $177,000 after buying an additional 100 shares in the last quarter. HB Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 5.9% during the 4th quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock valued at $257,000 after buying an additional 105 shares in the last quarter. Finally, Peterson Wealth Management boosted its holdings in shares of iShares Biotechnology ETF by 2.9% during the 3rd quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock valued at $458,000 after buying an additional 106 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $128.02 on Wednesday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The company’s fifty day moving average price is $134.81 and its 200-day moving average price is $129.75.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.